Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomer Meirson

Showing results (21-30 of 56) with videos related to

Pageof 6
Sort By:
Cancers|July 2, 2021
Immunotherapy Discontinuation in Metastatic Melanoma: Lessons from Real-Life Clinical ExperienceNethanel Asher, Noa Israeli-Weller, Ronnie Shapira-Frommer, et al.
European Journal of Haematology|June 29, 2023
Attrition and withdrawal in multiple myeloma randomized controlled trials: A systematic reviewStijn Hentzen, Tomer Meirson, Kelly Koehn, et al.
BMJ (Clinical Research Ed.)|December 14, 2023
Projecting complete redaction of clinical trial protocols (RAPTURE): redacted cross sectional studyNir Balaban, Ghulam Rehman Mohyuddin, Adi Kashi, et al.
The Journal of Cell Biology|November 15, 2017
Pyk2 and FAK differentially regulate invadopodia formation and function in breast cancer cellsAlessandro Genna, Stefanie Lapetina, Nikola Lukic, et al.
Cancers|December 30, 2025
Esophagectomy Versus Active Surveillance After Complete Response in Locally Advanced Esophageal Cancer: Retrospective AnalysisEfrat Gur, Meroslav Lutsyk, Tomer Meirson, et al.
Oncogene|October 18, 2022
A novel Pyk2-derived peptide inhibits invadopodia-mediated breast cancer metastasisShams Twafra, Chana G Sokolik, Tal Sneh, et al.
The Journal of Thoracic and Cardiovascular Surgery|August 6, 2015
Flow patterns in externally stented saphenous vein grafts and development of intimal hyperplasiaTomer Meirson, Eyal Orion, Carlo Di Mario, et al.
Clinical Genitourinary Cancer|May 14, 2026
Comparative and Critical Analysis of Immune-based Combinations for First-line Treatment of Metastatic Renal Cell CarcinomaTomer Meirson, Luciano Mutti, Daniel A Goldstein, et al.
Cancers|August 23, 2020
Real World Outcomes of Ipilimumab and Nivolumab in Patients with Metastatic MelanomaNethanel Asher, Guy Ben-Betzalel, Shaked Lev-Ari, et al.
Frontiers in Oncology|June 27, 2022
Trends in Women's Leadership of Oncology Clinical TrialsIthai Waldhorn, Ayelet Dekel, Anna Morozov, et al.
Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
Cancers|July 2, 2021
Immunotherapy Discontinuation in Metastatic Melanoma: Lessons from Real-Life Clinical ExperienceNethanel Asher, Noa Israeli-Weller, Ronnie Shapira-Frommer, et al.
European Journal of Haematology|June 29, 2023
Attrition and withdrawal in multiple myeloma randomized controlled trials: A systematic reviewStijn Hentzen, Tomer Meirson, Kelly Koehn, et al.
BMJ (Clinical Research Ed.)|December 14, 2023
Projecting complete redaction of clinical trial protocols (RAPTURE): redacted cross sectional studyNir Balaban, Ghulam Rehman Mohyuddin, Adi Kashi, et al.
The Journal of Cell Biology|November 15, 2017
Pyk2 and FAK differentially regulate invadopodia formation and function in breast cancer cellsAlessandro Genna, Stefanie Lapetina, Nikola Lukic, et al.
Cancers|December 30, 2025
Esophagectomy Versus Active Surveillance After Complete Response in Locally Advanced Esophageal Cancer: Retrospective AnalysisEfrat Gur, Meroslav Lutsyk, Tomer Meirson, et al.
Oncogene|October 18, 2022
A novel Pyk2-derived peptide inhibits invadopodia-mediated breast cancer metastasisShams Twafra, Chana G Sokolik, Tal Sneh, et al.
The Journal of Thoracic and Cardiovascular Surgery|August 6, 2015
Flow patterns in externally stented saphenous vein grafts and development of intimal hyperplasiaTomer Meirson, Eyal Orion, Carlo Di Mario, et al.
Clinical Genitourinary Cancer|May 14, 2026
Comparative and Critical Analysis of Immune-based Combinations for First-line Treatment of Metastatic Renal Cell CarcinomaTomer Meirson, Luciano Mutti, Daniel A Goldstein, et al.
Cancers|August 23, 2020
Real World Outcomes of Ipilimumab and Nivolumab in Patients with Metastatic MelanomaNethanel Asher, Guy Ben-Betzalel, Shaked Lev-Ari, et al.
Frontiers in Oncology|June 27, 2022
Trends in Women's Leadership of Oncology Clinical TrialsIthai Waldhorn, Ayelet Dekel, Anna Morozov, et al.
Pageof 6